المؤلفون: Gunter SJ; Harvard Medical School, Boston, Massachusetts, USA., Kim EJ; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: Ellen.Kim@pennmedicine.upenn.edu.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2024 Apr; Vol. 144 (4), pp. 855-861.e1. Date of Electronic Publication: 2023 Nov 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Sezary Syndrome*/drug therapy , Skin Neoplasms*/diagnosis , Skin Neoplasms*/drug therapy , Mycosis Fungoides*/diagnosis , Mycosis Fungoides*/drug therapy , Lymphoma, T-Cell, Cutaneous*/drug therapy, Humans ; Retrospective Studies

المؤلفون: Kim EJ; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Mangold AR; Mayo Clinic Arizona, Phoenix., DeSimone JA; Inova Schar Cancer Institute, Annandale, Virginia., Wong HK; University of Arkansas for Medical Sciences, Little Rock., Seminario-Vidal L; USF Health Morsani Center for Advanced Health Care, Tampa, Florida., Guitart J; Feinberg School of Medicine at Northwestern University, Chicago, Illinois., Appel J; PMG Research of Wilmington, Wilmington, North Carolina.; Campbell University-Sampson Regional Medical Center, Buies Creek, North Carolina., Geskin L; Columbia University Medical Center, New York, New York., Lain E; Austin Institute for Clinical Research, Pflugerville, Texas., Korman NJ; University Hospitals Cleveland Medical Center, Cleveland, Ohio., Zeitouni N; Medical Dermatology Specialists, University of Arizona, Phoenix., Nikbakht N; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Dawes K; Dawes Fretzin Dermatology Group, Indianapolis, Indiana., Akilov O; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Carter J; Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire., Shinohara M; University of Washington-Seattle Cancer Care Alliance, Seattle., Kuzel TM; Rush University Cancer Center, Chicago, Illinois., Piette W; Rush University Cancer Center, Chicago, Illinois., Bhatia N; Therapeutics Clinical Research, San Diego, California., Musiek A; Washington University School of Medicine, St Louis, Missouri., Pariser D; Virginia Clinical Research, Norfolk., Kim YH; Stanford University School of Medicine, Stanford, California., Elston D; Medical University of South Carolina, Charleston., Boh E; Tulane University, New Orleans, Louisiana., Duvic M; University of Texas-MD Anderson Cancer Center, Houston., Huen A; University of Texas-MD Anderson Cancer Center, Houston., Pacheco T; University of Colorado Cancer Center, Aurora., Zwerner JP; Vanderbilt Dermatology, Nashville, Tennessee., Lee ST; University of Maryland Comprehensive Cancer Center, Baltimore., Girardi M; Yale New Haven Hospital, New Haven, Connecticut., Querfeld C; City of Hope and Beckman Research Institute, Duarte, California., Bohjanen K; Department of Dermatology, University of Minnesota, Minneapolis., Olsen E; Duke University Medical Center, Durham, North Carolina., Wood GS; University of Wisconsin, Madison., Rumage A; Soligenix Inc, Princeton, New Jersey., Donini O; Soligenix Inc, Princeton, New Jersey., Haulenbeek A; Soligenix Inc, Princeton, New Jersey., Schaber CJ; Soligenix Inc, Princeton, New Jersey., Straube R; Soligenix Inc, Princeton, New Jersey., Pullion C; Soligenix Inc, Princeton, New Jersey., Rook AH; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Poligone B; Rochester Skin Lymphoma Medical Group, Fairport, New York.

المصدر: JAMA dermatology [JAMA Dermatol] 2022 Sep 01; Vol. 158 (9), pp. 1031-1039.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Cutaneous*/drug therapy , Lymphoma, T-Cell, Cutaneous*/pathology , Mycosis Fungoides*/pathology , Photochemotherapy*/adverse effects , Skin Neoplasms*/pathology, Adult ; Anthracenes ; Female ; Humans ; Male ; Middle Aged ; Ointments/therapeutic use ; Perylene/analogs & derivatives ; Photosensitizing Agents/adverse effects ; Treatment Outcome

المؤلفون: Weiner DM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Lewis DJ; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Spaccarelli NG; Department of Dermatology, Ohio State University, Columbus, Ohio, USA., Clark RA; Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA., Nasta SD; Department of Hematology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Loren AW; Department of Hematology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Rook AH; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kim EJ; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

المصدر: Dermatologic therapy [Dermatol Ther] 2022 Jul; Vol. 35 (7), pp. e15538. Date of Electronic Publication: 2022 May 09.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-8019 (Electronic) Linking ISSN: 13960296 NLM ISO Abbreviation: Dermatol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/therapy , Hematopoietic Stem Cell Transplantation*/adverse effects , Lymphoma, T-Cell*/pathology , Mycosis Fungoides*/etiology , Skin Neoplasms*/complications , Skin Neoplasms*/therapy, Humans ; Neoplasm Recurrence, Local/therapy ; Transplantation, Homologous/adverse effects

المؤلفون: Weiner DM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Clark AK; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Bhansali RS; Department of Hematology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Pappas-Taffer L; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Barta SK; Department of Hematology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Villasenor-Park J; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Haun PL; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Vittorio CC; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Rook AH; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Kim EJ; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Samimi SS; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

المصدر: Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jun; Vol. 47 (6), pp. 1200-1201. Date of Electronic Publication: 2022 Apr 01.

نوع المنشور: Letter

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Mycosis Fungoides*/drug therapy , Skin Neoplasms*/drug therapy, Humans ; Tacrolimus/adverse effects

المؤلفون: Querfeld C; City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California, USA. Electronic address: cquerfeld@coh.org., Geskin LJ; Department of Dermatology, Columbia University, New York, New York, USA., Kim EJ; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Scarisbrick JJ; University of Birmingham, Birmingham, United Kingdom., Quaglino P; Department of Dermatology, University of Turin, Turin, Italy., Papadavid E; Department of Dermatology, Attikon University Hospital, Athens, Greece., Angello JT; Helsinn Therapeutics Inc, Iselin, New Jersey, USA., Ortiz-Romero PL; Department of Dermatology, Hospital 12 de Octubre, Institute i+12, CIBERONC, Medical School, University Complutense, Madrid, Spain.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2021 Jun; Vol. 141 (6), pp. 1601-1604.e2. Date of Electronic Publication: 2021 Jan 08.

نوع المنشور: Equivalence Trial; Letter; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Mechlorethamine/*pharmacokinetics , Mycosis Fungoides/*drug therapy , Skin Neoplasms/*drug therapy, Absorption, Physiological ; Administration, Cutaneous ; Adult ; Aged ; Female ; Gels ; Humans ; Male ; Mechlorethamine/administration & dosage ; Middle Aged ; Mycosis Fungoides/pathology ; Ointments ; Skin/metabolism ; Skin/pathology ; Skin Neoplasms/pathology

المؤلفون: Kim EJ; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA. Ellen.Kim@pennmedicine.upenn.edu., Guitart J; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Querfeld C; Division of Dermatology, City of Hope, Duarte, CA, USA., Girardi M; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Musiek A; Division of Dermatology, Washington University School of Medicine, St. Louis, MO, USA., Akilov OE; Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Angello JT; Helsinn Therapeutics (U.S.) Inc., Iselin, NJ, USA., Bailey WL; Helsinn Therapeutics (U.S.) Inc., Iselin, NJ, USA., Geskin LJ; Department of Dermatology, Columbia University, New York, NY, USA.

المصدر: American journal of clinical dermatology [Am J Clin Dermatol] 2021 May; Vol. 22 (3), pp. 407-414. Date of Electronic Publication: 2021 Mar 03.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Alkylating/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Mechlorethamine/*administration & dosage , Mycosis Fungoides/*drug therapy , Skin Neoplasms/*drug therapy, Administration, Cutaneous ; Administration, Oral ; Aged ; Antineoplastic Agents, Alkylating/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Gels ; Humans ; Male ; Mechlorethamine/adverse effects ; Middle Aged ; Mycosis Fungoides/diagnosis ; Mycosis Fungoides/psychology ; Neoplasm Staging ; Prospective Studies ; Quality of Life ; Severity of Illness Index ; Skin Neoplasms/diagnosis ; Skin Neoplasms/psychology ; Treatment Outcome ; United States

المؤلفون: Geskin LJ; Department of Dermatology, Columbia University, New York, NY. Electronic address: ljg2145@cumc.columbia.edu., Kim EJ; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Angello JT; Medical Affairs and Research, Helsinn Therapeutics (US) Inc, Iselin, NJ., Kim YH; Department of Dermatology, Stanford Cancer Institute, Stanford, CA.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Feb; Vol. 21 (2), pp. 119-124.e4. Date of Electronic Publication: 2020 Dec 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Alkylating/*administration & dosage , Mechlorethamine/*administration & dosage , Mycosis Fungoides/*drug therapy , Skin Neoplasms/*drug therapy, Antineoplastic Agents, Alkylating/adverse effects ; Clinical Trials, Phase II as Topic ; Gels ; Humans ; Mechlorethamine/adverse effects ; Mycosis Fungoides/diagnosis ; Neoplasm Staging ; Randomized Controlled Trials as Topic ; Skin Neoplasms/diagnosis ; Time Factors ; Treatment Outcome

المؤلفون: Kim EJ; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: Ellen.Kim@uphs.upenn.edu., Geskin L; Department of Dermatology, Columbia University, New York, New York., Guitart J; Department of Dermatology, Northwestern University, Chicago, Illinois., Querfeld C; Division of Dermatology, City of Hope, Duarte, California., Girardi M; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Musiek A; Division of Dermatology, Washington University in St. Louis School of Medicine, Saint Louis, Missouri., Mink DR; Helsinn Therapeutics (US), Inc, Iselin, NJ., Williams MJ; Helsinn Therapeutics (US), Inc, Iselin, NJ., Angello JT; ICON Commercialization & Outcomes, Dublin, Ireland., Bailey WL; ICON Commercialization & Outcomes, Dublin, Ireland.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Sep; Vol. 83 (3), pp. 928-930. Date of Electronic Publication: 2020 Feb 20.

نوع المنشور: Letter; Observational Study

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Alkylating/*administration & dosage , Drug Eruptions/*epidemiology , Mechlorethamine/*administration & dosage , Mycosis Fungoides/*drug therapy , Skin Neoplasms/*drug therapy, Administration, Cutaneous ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Alkylating/adverse effects ; Drug Eruptions/diagnosis ; Drug Eruptions/etiology ; Female ; Gels ; Humans ; Male ; Mechlorethamine/adverse effects ; Middle Aged ; Mycosis Fungoides/complications ; Mycosis Fungoides/diagnosis ; Prospective Studies ; Quality of Life ; Severity of Illness Index ; Skin Neoplasms/complications ; Skin Neoplasms/diagnosis ; Treatment Outcome ; Young Adult

المؤلفون: Kim YH; Stanford University, Stanford, CA, USA. Electronic address: younkim@stanford.edu., Bagot M; Hôpital Saint Louis, APHP, Inserm U976, Université Paris 7, Paris, France., Pinter-Brown L; University of California Irvine, Irvine, CA, USA., Rook AH; University of Pennsylvania, Philadelphia, PA, USA., Porcu P; Thomas Jefferson University, Philadelphia, PA, USA., Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Whittaker S; Guy's and St Thomas' Hospital, London, UK., Tokura Y; Hamamatsu University School of Medicine, Hamamatsu, Japan., Vermeer M; Leiden University, Leiden, Netherlands., Zinzani PL; Institute of Hematology 'Seràgnoli', University of Bologna, Bologna, Italy., Sokol L; Moffitt Cancer Center, Tampa, FL, USA., Morris S; Guy's and St Thomas' Hospital, London, UK., Kim EJ; University of Pennsylvania, Philadelphia, PA, USA., Ortiz-Romero PL; Department of Dermatology, Institute i+12, Hospital 12 de Octubre Medical School, University Complutense, Madrid, Spain., Eradat H; UCLA Medical Center, Los Angeles, CA, USA., Scarisbrick J; University Hospital Birmingham, Birmingham, UK., Tsianakas A; University Hospital MÜnster, MÜnster, Germany., Elmets C; University of Alabama, Birmingham, AL, USA., Dalle S; Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France., Fisher DC; Dana-Farber Cancer Institute, Boston, MA, USA., Halwani A; University of Utah, Salt Lake City, UT, USA., Poligone B; Rochester Skin Lymphoma Center, Fairport, NY, USA., Greer J; Vanderbilt University Medical Center, Nashville, TN, USA., Fierro MT; University of Turin, Turin, Italy., Khot A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Musiek A; Washington University, St Louis, MO, USA., Shustov A; University of Washington, Seattle, WA, USA., Pro B; Northwestern University, Chicago, IL, USA., Geskin LJ; Columbia University Medical Center, New York, NY, USA., Dwyer K; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA., Moriya J; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA., Leoni M; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA., Humphrey JS; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA., Hudgens S; Clinical Outcome Solutions, Tucson, AZ, USA., Grebennik DO; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA., Tobinai K; National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Duvic M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.

مؤلفون مشاركون: MAVORIC Investigators

المصدر: The Lancet. Oncology [Lancet Oncol] 2018 Sep; Vol. 19 (9), pp. 1192-1204. Date of Electronic Publication: 2018 Aug 09.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Antineoplastic Agents, Immunological/*administration & dosage , Histone Deacetylase Inhibitors/*administration & dosage , Lymphoma, T-Cell, Cutaneous/*drug therapy , Mycosis Fungoides/*drug therapy , Sezary Syndrome/*drug therapy , Vorinostat/*administration & dosage, Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Australia ; Drug Administration Schedule ; Drug Resistance, Neoplasm ; Europe ; Female ; Histone Deacetylase Inhibitors/adverse effects ; Humans ; Japan ; Lymphoma, T-Cell, Cutaneous/mortality ; Lymphoma, T-Cell, Cutaneous/pathology ; Male ; Middle Aged ; Mycosis Fungoides/mortality ; Mycosis Fungoides/pathology ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Progression-Free Survival ; Sezary Syndrome/mortality ; Sezary Syndrome/pathology ; Time Factors ; United States ; Vorinostat/adverse effects

المؤلفون: Huang S; School of Medicine, Baylor College of Medicine, Houston, Texas, USA., Kim EJ; School of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lewis DJ; School of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chan WH; School of Medicine, Baylor College of Medicine, Houston, Texas, USA., Miranda RN; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Duvic M; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: The Australasian journal of dermatology [Australas J Dermatol] 2018 Aug; Vol. 59 (3), pp. 217-219. Date of Electronic Publication: 2017 Dec 26.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-0960 (Electronic) Linking ISSN: 00048380 NLM ISO Abbreviation: Australas J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Herpes Zoster/*complications , Mycosis Fungoides/*complications , Mycosis Fungoides/*diagnosis, Humans ; Male ; Middle Aged ; Mycosis Fungoides/pathology